AUSTIN (November 27, 2012)--The Texas Attorney General's Office said Tuesday it has resolved its case against a Dallas-based mail-order compounding pharmacy over a shipment of a misbranded drug ingredient that led to three deaths in the Pacific Northwest.
A statement from the office Tuesday says pharmacist Gary Osborn and his companies, Apothecure Inc. and SpectraPharm Inc., will pay $200,000 to the state, including $100,000 in civil penalties and will also agree to compound drugs to order and in a legal manner.
Osborn and ApotheCure received probation and $100,000 fines after pleading guilty to two misdemeanor criminal violations of the federal Food, Drug and Cosmetic Act.
The cases center on a February 2007 shipment of a gout drug containing some vials with dosages more than seven times stronger than shown on the label.
Autopsies showed three Oregon patients suffered fatal overdoses.